Cargando…
Oncogenic magnesium transporter 1 upregulates programmed death-1-ligand 1 expression and contributes to growth and radioresistance of glioma cells through the ERK/MAPK signaling pathway
Radiotherapy has been established as a major therapeutic modality for glioma, whereas new therapeutic targets are needed to prevent tumor recurrence. This study intends to explore the regulatory role of magnesium transporter 1 (MAGT1) in radiotherapy resistance of glioma through modulating ERK and p...
Autores principales: | Wu, Yuanyuan, Wang, Hongbing, Wei, Dongdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161830/ https://www.ncbi.nlm.nih.gov/pubmed/35416125 http://dx.doi.org/10.1080/21655979.2022.2037214 |
Ejemplares similares
-
Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance
por: Zhang, Li, et al.
Publicado: (2023) -
Expression of TIP-1 Confers Radioresistance of Malignant Glioma Cells
por: Han, Miaojun, et al.
Publicado: (2012) -
Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma
por: Song, Xing, et al.
Publicado: (2018) -
Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2018) -
Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair
por: Yang, Linlin, et al.
Publicado: (2021)